Webinar
Harnessing Nuclear Fusion to Produce Critical Medicine: A Conversation with Greg Piefer CEO of Shine Technologies
Many scientists see fusion as the future of energy. Per National Geographic, fusion is a “clean, plentiful fuel so efficient Earth’s entire annual supply could fit in a swimming pool. That’s the dream, but the science is there, too.”
See video policy below.
Wisconsin-based Shine Technologies is building a scalable approach to fusion that also solves significant problems along the way like the production of medical isotopes molybdenum-99 and lutetium-177 and the inspection of industrial components with nondestructive testing methods.
Watch above to hear more about this fascinating company in an exclusive, insightful interview with the visionary CEO of SHINE Technologies, Greg Piefer. With nearly two decades of executive management experience in technology companies, Greg is a passionate advocate for harnessing scientific advancements to serve and better humanity. Armed with a PhD in nuclear engineering and a background in physics and electrical and computer engineering, all from the prestigious University of Wisconsin–Madison, Greg brings a wealth of expertise to the forefront of innovation.
Our host, Greg Baker, a Managing Partner of Alumni Ventures funds Bascom Ventures and Towerview Ventures, has a track record of over 100 investments in pioneering companies like SHINE Medical, Axiom Space, and many more.
Be part of this exciting conversation as we explore the dynamic fusion of science, technology, and humanity’s betterment.
See video policy below.
Note: You must be accredited to invest in venture capital. Important disclosure information can be found at av-funds.com/disclosures.
About your presenters
Overview:
Greg began as a Managing Partner with Alumni Ventures in 2017, where he has helped lead more than 100 investments across a wide range of sectors. He is the Founder of Bascom Ventures and also manages Towerview Ventures, Alumni Ventures’ Duke-focused fund, the Foundation Fund, and the CIO Select Fund. His portfolio includes innovative companies such as Axiom Space, SHINE Medical, American Gene Technologies, Juvena Therapeutics, Centaur Health Holdings, Canela Media, and Matchwell.
At Alumni Ventures, Greg has been a generalist investor, but his passion lies in infrastructure—investing in the tools and platforms that will enable and support the next generation of transformative industries, particularly in energy. He is especially interested in how foundational technologies create ripple effects that unlock growth across healthcare, frontier tech, and industrial innovation.
Prior to joining Alumni Ventures, Greg built a successful career as a senior executive across the electrical products, packaging, and chemical industries, with expertise spanning corporate leadership, business development, startups, M&A, and strategic growth. He began his career as a Design Engineer at Texas Instruments before pursuing his MBA at Duke University’s Fuqua School of Business. He also holds a Bachelor of Science degree in Mechanical Engineering from the University of Wisconsin.
Funds actively worked on:
- Bascom Ventures
- Towerview Ventures
- Foundation Fund
- CIO Select Fund
Investment Lens:
Greg’s passion lies in infrastructure—tools and platforms that enable and support the next generation of transformative industries, particularly in energy. He is particularly interested in how foundational technologies create ripple effects that drive growth across:
- Healthcare
- Frontier technologies
- Industrial innovation
Representative investments include:
- Axiom Space (pioneering the commercial space industry)
- Juvena Therapeutics (unlocking regenerative medicines)
- Canela Media (leading digital media company serving Latino audiences)
Learn How To Invest In Companies In This Sector With Alumni Ventures:
HealthTech Fund >>>
Founder & CEO, SHINE Technologies
As founder and CEO of SHINE Technologies, Greg has nearly 20 years of executive management experience at growth-stage technology companies. His passion is the growth of technology companies that take scientific advancement to commercialization, providing the opportunity to serve and better humanity. Greg holds a PhD in nuclear engineering and BS degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison.